Preventing Loss of Independence through Exercise (PLIE) in Persons with Dementia

预防痴呆症患者通过运动丧失独立性 (PLIE)

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The goal of the proposed study is to perform a randomized, controlled trial (RCT) to test the efficacy of a novel integrative exercise program called Preventing Loss of Independence through Exercise (PLIÉ) on function and quality of life in older Veterans living in the community with dementia. Dementia is a devastating condition that affects nearly 1 in 10 older veterans (~1 million individuals). Current dementia medications have minimal impact on function and quality of life and do not stop or slow the disease course; however, there is growing evidence that behavioral interventions such as exercise have a variety of beneficial effects in individuals with dementia. PLIÉ was developed based on recent discoveries in neuroscience and experimental psychology that have found that, although explicit memory (the ability to consciously recall new information) is impaired in individuals with dementia, implicit memory (unconscious learning that typically occurs through repeated exposure) is relatively preserved. Therefore, PLIÉ focuses on training procedural memory (unconscious learning of procedures) to build the strength and capacity to perform the movements that are most needed for daily function (e.g., transitioning safely from sitting to standing). In addition, to maximize the benefits of the training, PLIÉ integrates elements of Eastern and Western exercise modalities to develop mindful body awareness and enhance social connection. We have recently completed a pilot study of the PLIÉ program at an adult day health center in San Francisco, CA, finding that it was associated with clinically meaningful improvements in cognitive function, physical performance and quality of life as well as reduced caregiver burden when compared with usual care at the facility. The proposed study will enable us to build on these exciting pilot study results by performing a full-scale RCT at adult day health centers in Northern California. Most VA Medical Centers currently contract with community-based organizations to provide adult day health care to eligible Veterans with dementia. Therefore, sites for the current study will be adult day health centers that have current contracts with either the San Francisco VA (SFVA) or Palo Alto VA (PAVA). Within each center, study participants will be randomly assigned to receive the PLIÉ intervention program (45 minutes, 2 days/week, 6 months) or Usual Care (UC) control (standard center activities, 45 minutes, 2 days/week, 6 months) (N=144, 72/group). Our co-primary outcomes will be 6-month change in cognitive function (Alzheimer's Disease Assessment Scale - cognitive subscale, ADAS-cog), independence (Functional Independence Measure, FIM) and quality of life (Quality of Life in Alzheimer's Disease, QOL-AD). Changes in caregiver burden (Caregiver Burden Inventory, CBI) will be examined as a secondary outcome. We also propose to determine whether the effects of PLIÉ are maintained over 6 months after the intervention period; thus, all outcomes will be assessed at baseline, 6 months and 12 months. The proposed project will address a critically important Veterans' health problem related to optimizing functional status and quality of life in older Veterans with dementia. It is directly responsive to Request for Applications (RFA) RX-14-011 (RR&D Merit Review Award for Research on Amyotrophic Lateral Sclerosis, Parkinson's Disease and Alzheimer's Disease), which has identified "pioneering new and innovative rehabilitation methodologies to restore function and improve quality of life for Veterans living with [these] neurodegenerative diseases" as a "major focus." Many patients and caregivers currently feel that little is being done to help individuals with dementia maintain function and quality of life. Our proposed study will utilize rigorous research methods to test the efficacy of a highly innovative and promising new program for older adults with dementia. If our program is successful, we will work with VA and community-based organization to implement PLIÉ more broadly.
 描述(由申请人提供): 拟议研究的目标是进行一项随机对照试验(RCT),以测试一种名为“通过运动预防失去独立性”(PLIÉ)的新型综合运动计划对生活在社区的老年退伍军人的功能和生活质量的功效痴呆症是一种毁灭性的疾病,影响着近十分之一的老年退伍军人(约 100 万人),目前的痴呆症药物对功能和生活质量的影响很小,并且不能阻止或减缓疾病进程。证据表明PLIÉ 是基于神经科学和实验心理学的最新发现而开发的,例如运动等行为干预措施对痴呆症患者有多种有益作用,这些发现发现,尽管患有痴呆症的人的外显记忆(有意识地回忆新信息的能力)受到损害。痴呆症中,内隐记忆(通常通过重复接触而发生的无意识学习)相对保留,因此,PLIÉ 专注于训练程序记忆(程序的无意识学习),以增强执行日常功能最需要的动作的力量和能力(例如,安全地从此外,为了最大限度地发挥培训的效益,PLIÉ 整合了东西方运动方式的元素,以培养正念身体意识并增强社交联系。我们最近在旧金山的一家成人日间健康中心完成了 PLIÉ 计划的试点研究。 ,加利福尼亚州,发现与该机构的常规护理相比,它与认知功能、身体表现和生活质量的临床有意义的改善以及减轻的护理人员负担相关。拟议的研究将使我们能够在这些令人兴奋的试点研究的基础上继续进行。通过执行结果目前,大多数退伍军人事务部医疗中心都与社区组织签订了合同,为符合条件的患有痴呆症的退伍军人提供成人日间医疗服务。目前与旧金山 VA (SFVA) 或帕洛阿尔托 VA (PAVA) 签订了合同。在每个中心内,研究参与者将被随机分配接受 PLIÉ 干预计划(45 分钟,每周 2 天,6 个月)或常规干预计划。护理 (UC) 控制(标准中心活动,45 分钟,每周 2 天,6 个月)(N=144,72 人/组)我们的共同主要结果将是认知功能的 6 个月变化(阿尔茨海默病评估量表 - 认知分量表、ADAS)。 -cog)、独立性(功能独立性测量,FIM)和生活质量(阿尔茨海默病的生活质量,QOL-AD)。库存、CBI)将作为次要结果进行检查,以确定 PLIÉ 的效果是否在干预期后保持超过 6 个月;因此,所有结果将在基线、6 个月和 12 个月的项目中进行评估。解决与优化患有痴呆症的老年退伍军人的功能状态和生活质量相关的至关重要的退伍军人健康问题。 申请请求 (RFA) RX-14-011(RR&D 肌萎缩侧索硬化症、帕金森病和阿尔茨海默病研究优异评审奖),该奖项确定了“开创性的新型创新康复方法,以恢复退伍军人的功能并提高生活质量”患有[这些]神经退行性疾病”作为“主要焦点”。许多患者和护理人员目前认为,在帮助痴呆症患者维持功能和生活质量方面几乎没有采取任何措施。拟议的研究将利用严格的研究方法来测试针对患有痴呆症的老年人的高度创新和有前途的新计划的有效性。如果我们的计划成功,我们将与 VA 和社区组织合作,更广泛地实施 PLIÉ。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Deborah E. Barnes其他文献

Why review articles on the health effects of passive smoking reach different conclusions.
为什么有关被动吸烟对健康影响的评论文章得出不同的结论。
  • DOI:
    10.1001/jama.279.19.1566
  • 发表时间:
    1998-05-20
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Deborah E. Barnes;L. Bero
  • 通讯作者:
    L. Bero
Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research.
行业资助的研究和利益冲突:对烟草行业通过室内空气研究中心赞助的研究进行分析。
Transcription coupled repair of 8-oxoguanine in murine cells: the ogg1 protein is required for repair in nontranscribed sequences but not in transcribed sequences.
鼠细胞中 8-氧代鸟嘌呤的转录偶联修复:非转录序列的修复需要 ogg1 蛋白,但转录序列则不需要。
Scientific quality of original research articles on environmental tobacco smoke
关于环境烟草烟雾的原创研究文章的科学质量
  • DOI:
    10.1136/tc.6.1.19
  • 发表时间:
    1997-03-01
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Deborah E. Barnes;L. Bero
  • 通讯作者:
    L. Bero
Prediction of Recovery, Dependence or Death in Elders Who Become Disabled During Hospitalization
住院期间残疾老年人的康复、依赖或死亡预测
  • DOI:
    10.1007/s11606-012-2226-y
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Deborah E. Barnes;Kala M. Mehta;W. J. Boscardin;R. Fortinsky;Robert M. Palmer;Katharine A. Kirby;C. Landefeld
  • 通讯作者:
    C. Landefeld

Deborah E. Barnes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Deborah E. Barnes', 18)}}的其他基金

A Novel Algorithm to Identify People with Undiagnosed Alzheimer's Disease and Related Dementias
一种识别未确诊阿尔茨海默病和相关痴呆症患者的新算法
  • 批准号:
    10696912
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Novel Algorithm to Identify People with Undiagnosed Alzheimer's Disease and Related Dementias
一种识别未确诊阿尔茨海默病和相关痴呆症患者的新算法
  • 批准号:
    10696912
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
  • 批准号:
    10324919
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
  • 批准号:
    10493302
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
  • 批准号:
    10747235
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
EXTENDING INDEPENDENCE AND QUALITY OF LIFE FOR PEOPLE WITH ALZHEIMER'S DISEASE OR DEMENTIA THROUGH TELEHEALTH PROGRAM DELIVERY
通过远程医疗计划的实施,提高阿尔茨海默病或痴呆症患者的独立性和生活质量
  • 批准号:
    10204865
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.
使用电子健康记录数据低成本检测痴呆症:在务实、以患者为中心的试验中验证和测试 eRADAR 算法。
  • 批准号:
    10443874
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
使用 EHR 阿尔茨海默氏症和痴呆症风险评估规则 (eRADAR) 识别和支持未确诊的痴呆症患者:一项试点临床试验
  • 批准号:
    10665566
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.
使用电子健康记录数据低成本检测痴呆症:在务实、以患者为中心的试验中验证和测试 eRADAR 算法。
  • 批准号:
    10091300
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
使用 EHR 阿尔茨海默氏症和痴呆症风险评估规则 (eRADAR) 识别和支持未确诊的痴呆症患者:一项试点临床试验
  • 批准号:
    10409614
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
  • 批准号:
    82372499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
  • 批准号:
    82373465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
  • 批准号:
    82300208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
  • 批准号:
    10819340
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686545
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
减少年轻成年睾丸癌幸存者不良后果的生物行为干预
  • 批准号:
    10736501
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
  • 批准号:
    10734831
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
  • 批准号:
    10715238
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了